35 GATEHOUSE DRIVE, WALTHAM, MA
News, Securities Holder Rights or Indentures
Syndax Pharmaceuticals Approves 2026 Equity Incentive Plan
Announces Private Placement of $250.0 Million of Convertible Senior Notes
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
Board Approves Amendments to Bylaws; Uncertificated Shares Effective December...
Reports Third Quarter 2025 Financial Results and Provides Business Update
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership